The results of the present study showed that DFMO, a specific inhibitor of ODC, induced apoptosis by increasing the expression of AP-1 and JNK phosphorylation in ovarian cancer cells either alone or in combination with cisplatin. The gene discussed is FOS; the disease is ovarian cancer.